Asclemed USA Inc. (dba Enovachem Pharmaceuticals) is recalling specific lots of Methylprednisolone Tablets USP 4 mg (21-count blister cards) because the printed dosing instructions on the packaging may be misaligned or illegible. This recall affects medication distributed by DocRx and relabeled by Enovachem Pharmaceuticals. Because these instructions guide how a patient should taper their dosage, incorrect or unreadable directions could lead to improper medication use. Consumers should contact their healthcare provider or pharmacist immediately to discuss their treatment and how to obtain a legible replacement.
The misaligned print makes the critical dosing instructions on the blister card difficult or impossible to read. This poses a risk that patients may take the wrong amount of medication, which is particularly dangerous for steroids like methylprednisolone that require precise tapering of doses.
Contact healthcare provider or pharmacist; return to pharmacy.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.